MyAverix Finance
SHE · Healthcare
Hubei Goto Biopharm Co.Ltd. (300966)
Biotechnology
Hubei Goto Biopharm Co.Ltd. (300966) is listed on SHE in the Healthcare sector. Industry: Biotechnology. As of 2026-03-28, reported market cap is $2.39B, P/E ratio is 18.00, net margin is -7.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300966
Hubei Goto Biopharm Co.Ltd. (300966) — FAQ
What is Hubei Goto Biopharm Co.Ltd.'s market cap?
Hubei Goto Biopharm Co.Ltd. (300966) has a reported market cap of $2.39B (data as of 2026-03-28).
What is 300966's P/E ratio?
The price-to-earnings (P/E) ratio for Hubei Goto Biopharm Co.Ltd. (300966) is 18.00 (data as of 2026-03-28).
Does Hubei Goto Biopharm Co.Ltd. pay a dividend?
Dividend yield is not available in the current snapshot for Hubei Goto Biopharm Co.Ltd. (300966). Check the MyAverix Finance app for the latest dividend data.
What sector is Hubei Goto Biopharm Co.Ltd. in?
Hubei Goto Biopharm Co.Ltd. (300966) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 300966 listed on?
300966 is listed on SHE.
What is Hubei Goto Biopharm Co.Ltd.'s net margin?
Hubei Goto Biopharm Co.Ltd. (300966) reports a net margin of -7.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.